Big Bets Aim To Jolt Heart Drug Sales Back To Life

Patent expiries mean annual sales of 15 different categories of heart drugs are set to fall by more than a quarter by 2017, from $83 billion in 2011 to $60 billion, according to consensus analyst forecasts compiled by Thomson Reuters Pharma.

Pfizer Settles Government Bribery Complaints

Pfizer, BYU Go To Court In May, Celebrex and Millions Of Dollars At Stake
Among the charges: Pfizer's China subsidiary was accused of offering a program where doctors could claim cell phones and other goodies based on how many prescriptions they doled out of the company's products.
More news

Scientists Trace Timeline Of Alzheimer's Slow, Deadly Path

A new study offers a timeline of changes in spinal fluid, brain size, the appearance of brain plaques and other factors that precede the onset of Alzheimer's in people who are genetically predestined to develop the brain-wasting disease.
IBTimes Logo

Pfizer Yanks Breast, Colon Claims For Centrum Vitamins

A consumer group said Pfizer partly based its claims that Centrum products promote breast and colon health on the presence of vitamin D in the products, despite inconsistent or inconclusive evidence of vitamin D's protective role against breast and colon cancer.
IBTimes Logo

India To Give Free Generic Drugs To Hundreds Of Millions

From city hospitals to tiny rural clinics, India's public doctors will soon be able to prescribe free generic drugs to all comers, vastly expanding access to medicine in a country where public spending on health was just $4.50 per person last year.
IBTimes Logo

GSK Settles Healthcare Fraud Case For $3 Billion

GSK targeted the antidepressant Paxil to patients under age 18 when it was approved for adults only, and it pushed the drug Wellbutrin for uses it was not approved for, including weight loss and treatment of sexual dysfunction, according to an investigation led by the U.S. Justice Department.
IBTimes Logo

Promoting Health? It's All In The Game

Gamification - turning boring, unpleasant but necessary tasks into an online game - is a new way of thinking that is gaining momentum among drugmakers and health campaigners.
Taking A Pill

Tafamidis: US Panel Split On Pfizer Rare Disease Drug

A U.S. health advisory panel on Thursday issued a split vote on data for Pfizer Inc's drug to treat a rare neurodegenerative disease. The U.S. Food and Drug Administration panel voted 13 to 4 that the drug did not show that it met the main goal in a study in treating the fatal condition.

'Breakthrough Drugs': FDA May Speed Approval Process

Experimental drugs that show a big effect early in development for treating serious or life-threatening diseases would get a faster and cheaper path to U.S. approval, under a proposal likely to become law this year. U.S. drug regulators would be able to label such treatments breakthrough therapies, and work with companies to speed up clinical trials, for example by testing the drugs for a shorter time or enrolling fewer patients.


IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.